MAY 8, 2024
Q1 2024 Interim Report
Key News
MAY 7, 2024
Fentanyl awareness day: The synthetic opioid fentanyl increasingly poisons young Americans
MAY 2, 2024
Invitation to the presentation of Orexo's Q1 2024 Interim Report
Read all documents related to the refinancing of the existing bond - MARCH 2024
A commercial stage pharmaceutical company with three revenue generating pharmaceutical products
Development pipeline targeting large medical needs
AmorphOX® - a novel world leading nasal delivery technology leading to a new wave of products